Abstract
Previous studies regarding effects of caffeine on lipids focused mainly on coffee consumption, the real association of serum caffeine concentrations with blood lipids is unclear. 814 caffeine-drug users who had taken any caffeine/caffeine-containing pharmaceutical products and 623 nonusers without any drug use in the last seven days before the medical interview were identified from German National Health Surveys from 1984 to 1999. Serum caffeine concentrations were measured by using EIA for caffeine-drug users and nonusers in the same laboratory. Blood lipids were measured routinely for all survey participants. The association of caffeine concentrations with blood lipids was established by means of partial correlation analysis and regression analysis. After controlling for influence factors, caffeine concentrations were closely positively related to triglycerides in caffeine-drug users (male r = 0.245, p < 0.001; female: r = 0.117, p = 0.018) and related to HDL-C in female nonusers (r = 0.245, p < 0.001). No associations were found between caffeine concentrations and total cholesterol and LDL-C levels in any groups of our study. Acute intake of caffeine might increase triglycerides levels especially in men while chronic intake of caffeine might be weakly but positively associated with HDL-C concentrations in women. The effects of caffeine on the pathogenesis of cardiovascular diseases should be further confirmed through epidemiological studies.
Similar content being viewed by others
References
BB Fredholm K Battig J Holmen A Nehlig EE. Zvartau (1999) ArticleTitleActions of caffeine in the brain with special reference to factors that contribute to its widespread use Pharmacol Rev 51 83–133 Occurrence Handle1:CAS:528:DyaK1MXitFWgurk%3D Occurrence Handle10049999
PW Wilson RJ Garrison WB Kannel DL McGee WP. Castelli (1989) ArticleTitleIs coffee consumption a contributor to cardiovascular disease? Insights from the Framingham study. Arch Intern Med 149 1169–1172 Occurrence Handle1:STN:280:DyaL1M3ksF2hsA%3D%3D
TM Chou NL. Benowitz (1994) ArticleTitleCaffeine and coffee: effects on health and cardiovascular disease Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 109 173–189 Occurrence Handle10.1016/1367-8280(94)90130-9 Occurrence Handle1:STN:280:DyaK2M7oslKhsg%3D%3D Occurrence Handle7881818
A Tverdal T Stensvold K Solvoll OP Foss P Lund-Larsen K. Bjartveit (1990) ArticleTitleCoffee consumption and death from coronary heart disease in middle aged Norwegian men and women BMJ 300 566–569 Occurrence Handle1:STN:280:DyaK3c3ht12itg%3D%3D Occurrence Handle2108750 Occurrence Handle10.1136/bmj.300.6724.566
DE Grobbee EB Rimm E Giovannucci G Colditz M Stampfer W. Willett (1990) ArticleTitleCoffee, caffeine, and cardiovascular disease in men N Engl J Med 323 1026–1032 Occurrence Handle1:STN:280:DyaK3M%2FhsFajsg%3D%3D Occurrence Handle2215561 Occurrence Handle10.1056/NEJM199010113231504
SH Jee J He LJ Appel PK Whelton I Suh MJ. Klag (2001) ArticleTitleCoffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials Am J Epidemiol 153 353–362 Occurrence Handle10.1093/aje/153.4.353 Occurrence Handle1:STN:280:DC%2BD3MvgvVGjug%3D%3D Occurrence Handle11207153
BR Davis JD Curb NO Borhani RJ Prineas A. Molteni (1988) ArticleTitleCoffee consumption and serum cholesterol in the hypertension detection and follow-up program Am J Epidemiol 128 124–136 Occurrence Handle1:STN:280:DyaL1c3ltVagug%3D%3D Occurrence Handle3381821
K Kokjohn M Graham M. McGregor (1993) ArticleTitleThe effect of coffee consumption on serum cholesterol levels J Manipulative Physiol Ther 16 327–335 Occurrence Handle1:STN:280:DyaK3szks12hsQ%3D%3D Occurrence Handle8345316
R Urgert T Vliet Particlevan PL Zock MB. Katan (2000) ArticleTitleHeavy coffee consumption and plasma homocysteine: a randomized controlled trial in healthy volunteers Am J Clin Nutr 72 1107–1110 Occurrence Handle1:CAS:528:DC%2BD3cXnvF2nt70%3D Occurrence Handle11063436
MR Olthof PC Hollman PL Zock MB. Katan (2001) ArticleTitleConsumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentration in humans Am J Clin Nutr 73 532–538 Occurrence Handle1:CAS:528:DC%2BD3MXhs1Sgs74%3D Occurrence Handle11237928
J Rooij Particlevan GH Stegen Particlevan der RC Schoemaker et al. (1995) ArticleTitleA placebo-controlled parallel study of the effect of two types of coffee oil on serum lipids and transaminases: identification of chemical substances involved in the cholesterol-raising effect of coffee Am J Clin Nutr 61 1277–1283 Occurrence Handle7762531
MP Weusten-Vander Wouw MB Katan R Viani et al. (1994) ArticleTitleIdentity of the cholesterol-raising factor from boiled coffee and its effects on liver function enzymes J Lipid Res 35 721–733 Occurrence Handle1:CAS:528:DyaK2cXis1ymt7w%3D Occurrence Handle7911820
B Christensen A Mosdol L Retterstol S Landaas DS. Thelle (2001) ArticleTitleAbstention from filtered coffee reduces the concentrations of plasma homocysteine and serum cholesterol – a randomized controlled trial Am J Clin Nutr 74 302–307 Occurrence Handle1:CAS:528:DC%2BD3MXms12htbg%3D Occurrence Handle11522552
R Urgert S Meyboom M Kuilman et al. (1996) ArticleTitleComparison of effect of cafetiere and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial BMJ 313 1362–1366 Occurrence Handle1:CAS:528:DyaK2sXivFShug%3D%3D Occurrence Handle8956701
A D’Amicis C Scaccini G Tomassi M Anaclerio R Stornelli A. Bernini (1996) ArticleTitleItalian style brewed coffee: effect on serum cholesterol in young men Int J Epidemiol 25 513–520 Occurrence Handle1:STN:280:BymA38vos1Q%3D Occurrence Handle8671551
InstitutionalAuthorNameGCP Study Group. (1988) ArticleTitleThe German Cardiovascular Prevention Study (GCP): design and methods. GCP Study Group Eur Heart J 9 1058–1066
HU Melchert B Görsch H. Hoffmeister (1995) Nichtstationäre Arzneimittelanwendung und subjektive Arzneimittelverträglichkeit in der bundesdeutschen Wohnbevölkerung der 25- bis 69jährigen: zur Epidemiologie des Arzneimittelkonsums und der unerwünschten Arzneimittelwirkungen; Ergebnisse der Erhebung des ersten Nationalen Untersuchungs-Surveys 1984–1986 MMV Medizin Verlag München
H Hoffmeister H Hüttner H Stolzenberg H Lopez J. Winkler (1992) Sozialer Status und Gesundheit: Nationaler Gesundheits-Surveys 1984–1986 MMV Medizin Verlag München
H Knopf HU. Melchert (2003) Bundes-Gesundheitssurvey: Arzneimittelgebrauch Robert Koch-Institut Berlin
WT Friedewald RI Levy DS. Fredrickson (1972) ArticleTitleEstimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 499–502 Occurrence Handle1:CAS:528:DyaE38Xkslagsbw%3D Occurrence Handle4337382
CA Carson JA Cauley AW. Caggiula (1993) ArticleTitleRelation of caffeine intake to blood lipids in elderly women Am J Epidemiol 138 94–100 Occurrence Handle1:STN:280:DyaK3szktlWhtw%3D%3D Occurrence Handle8342534
FA Sedor KA Schneider S. Heyden (1991) ArticleTitleEffect of coffee on cholesterol and apolipoproteins, corroborated by caffeine levels Am J Prev Med 7 391–396 Occurrence Handle1:STN:280:DyaK387mt1eqsw%3D%3D Occurrence Handle1790048
AA Bak DE. Grobbee (1991) ArticleTitleCaffeine, blood pressure, and serum lipids Am J Clin Nutr 53 971–975 Occurrence Handle1:STN:280:DyaK3M7otFGqsA%3D%3D Occurrence Handle2008876
J Tuomilehto A Tanskanen P Pietinen et al. (1987) ArticleTitleCoffee consumption is correlated with serum cholesterol in middle-aged Finnish men and women J Epidemiol Community Health 41 237–242 Occurrence Handle1:STN:280:DyaL1c7ntFaksQ%3D%3D Occurrence Handle3443818 Occurrence Handle10.1136/jech.41.3.237
M Dusseldorp Particlevan MB Katan T Vliet Particlevan PN Demacker AF. Stalenhoef (1991) ArticleTitleCholesterol-raising factor from boiled coffee does not pass a paper filter Arterioscler Thromb 11 586–593 Occurrence Handle2029499
A Aro J Teirila CG. Gref (1990) ArticleTitleDose-dependent effect on serum cholesterol and apoprotein B concentrations by consumption of boiled, non-filtered coffee Atherosclerosis 83 257–261 Occurrence Handle1:STN:280:DyaK3M%2FlsVOjsA%3D%3D Occurrence Handle2242101
M Dusseldorp Particlevan MB Katan PN. Demacker (1990) ArticleTitleEffect of decaffeinated versus regular coffee on serum lipoproteins. A 12 week double-blind trial Am J Epidemiol 132 33–40 Occurrence Handle2356812
HR Superko PT BortzW Williams SuffixJr. JJ Albers PD. Wood (1991) ArticleTitleCaffeinated and decaffeinated coffee effects on plasma lipoprotein cholesterol, apolipoproteins, and lipase activity: a controlled, randomized trial Am J Clin Nutr 54 599–605 Occurrence Handle1:CAS:528:DyaK3MXmsFCmsLc%3D Occurrence Handle1877516
Jacobson KA, von Lubitz DK, Daly JW, Fredholm BB. (2003) Adenosine receptor ligands: differences with acute versus chronic treatment. Trends Pharmacol Sci
M Johnson-Kozlow D Kritz-Silverstein E Barrett-Connor D. Morton (2002) ArticleTitleCoffee consumption and cognitive function among older adults Am J Epidemiol 156 842–850 Occurrence Handle12397002
E Bona U Aden BB Fredholm H. Hagberg (1995) ArticleTitleThe effect of long term caffeine reatment on hypoxic-ischemic brain damage in the neonate Pediatr Res 38 312–318 Occurrence Handle1:CAS:528:DyaK2MXosVChs78%3D Occurrence Handle7494652
KA Rudolphi M Keil J Fastbom BB. Fredholm (1989) ArticleTitleIschaemic damage in gerbil hippocampus is reduced following upregulation of adenosine (A1) receptors by caffeine treatment Neurosci Lett 103 275–280 Occurrence Handle1:CAS:528:DyaL1MXlvVOns74%3D Occurrence Handle2812514
A Rosengren A Dotevall L Wilhelmsen D Thelle S. Johansson (2004) ArticleTitleCoffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study J Intern Med 255 89–95 Occurrence Handle1:STN:280:DC%2BD3sngs1Sgsg%3D%3D Occurrence Handle14687243
EE Agardh S Carlsson A Ahlbom et al. (2004) ArticleTitleCoffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women J Intern Med 255 645–652 Occurrence Handle1:STN:280:DC%2BD2c3ltVSltA%3D%3D Occurrence Handle15147528
J Tuomilehto G Hu S Bidel J Lindstrom P. Jousilahti (2004) ArticleTitleCoffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women JAMA 291 1213–1219 Occurrence Handle1:CAS:528:DC%2BD2cXhvFOht7w%3D Occurrence Handle15010442
GW Ross RD Abbott H Petrovitch et al. (2000) ArticleTitleAssociation of coffee and caffeine intake with the risk of Parkinson disease JAMA 283 2674–2679 Occurrence Handle1:STN:280:DC%2BD3c3otVSnug%3D%3D Occurrence Handle10819950
A Ascherio SM Zhang MA Hernan et al. (2001) ArticleTitleProspective study of caffeine consumption and risk of Parkinson’s disease in men and women Ann Neurol 50 56–63 Occurrence Handle1:CAS:528:DC%2BD3MXlt12gurg%3D Occurrence Handle11456310
TR Mikuls JR Cerhan LA Criswell et al. (2002) ArticleTitleCoffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women’s Health Study Arthritis Rheum 46 83–91 Occurrence Handle11817612
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Du, Y., Melchert, HU., Knopf, H. et al. Association of serum caffeine concentrations with blood lipids in caffeine-drug users and nonusers – Results of German National Health Surveys from 1984 to 1999. Eur J Epidemiol 20, 311–316 (2005). https://doi.org/10.1007/s10654-004-7536-x
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10654-004-7536-x